Sanofi launches its $3.68 billion offer for Principia Biopharma

PARIS (Reuters) – Sanofi announced Friday the launch of its tender offer to acquire Principia Biopharma, a U.S. biotech company specializing in the development of treatments for autoimmune and allergic diseases, which will strengthen its portfolio in immunology.

The transaction, through a repurchase of all outstanding shares at a price of $100 per share, represents a cash transaction valued at approximately $3.68 billion ('3.1 billion) and is expected to close in the fourth quarter of 2020.

The offer, which closed on August 16, will expire on September 25.

Claude Chendjou

close

Oh salut toi đź‘‹
Ravi de vous rencontrer.

Inscrivez-vous pour recevoir les dernières nouvelles dans votre boîte de réception, tous les jours.

Share on
Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Subscribe to Our Newsletter

Oh hi there đź‘‹
It’s nice to meet you.

Sign up to receive latest news in your inbox, every day.

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Follow us on Instagram!

Apple Watch Series 6

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Sanofi launches its $3.68 billion offer for Principia Biopharma


PARIS (Reuters) - Sanofi announced Friday the launch of its tender offer to acquire Principia Biopharma, a U.S. biotech company specializing in the development of treatments for autoimmune and allergic diseases, which will strengthen its portfolio in immunology.


The transaction, through a repurchase of all outstanding shares at a price of $100 per share, represents a cash transaction valued at approximately $3.68 billion ('3.1 billion) and is expected to close in the fourth quarter of 2020.


The offer, which closed on August 16, will expire on September 25.


Claude Chendjou

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Subscribe to Our Newsletter

Oh hi there đź‘‹
It’s nice to meet you.

Sign up to receive latest news in your inbox, every day.

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Follow us on Instagram!

Apple Watch Series 6

Sanofi launches its $3.68 billion offer for Principia Biopharma

Advertisement

Oh hi there đź‘‹
It’s nice to meet you.

Sign up to receive latest news in your inbox, every day.